252 related articles for article (PubMed ID: 29458778)
1. Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis.
Gandini S; Palli D; Spadola G; Bendinelli B; Cocorocchio E; Stanganelli I; Miligi L; Masala G; Caini S
Crit Rev Oncol Hematol; 2018 Feb; 122():1-9. PubMed ID: 29458778
[TBL] [Abstract][Full Text] [Related]
2. The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis.
Heisel AGU; Vuurboom MD; Daams JG; de Rie MA; Vogt L; van den Born BH; Olde Engberink RHG
Vascul Pharmacol; 2023 Jun; 150():107173. PubMed ID: 37084802
[TBL] [Abstract][Full Text] [Related]
3. Photosensitizing antihypertensive medication and risk of skin cancer among postmenopausal women.
Hou A; Li Y; Shadyab AH; Han J; Eaton CB; Qureshi A; Cho E
J Dtsch Dermatol Ges; 2024 Feb; 22(2):186-194. PubMed ID: 38345266
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
[TBL] [Abstract][Full Text] [Related]
5. Use of antihypertensive drugs and risk of skin cancer.
Schmidt SA; Schmidt M; Mehnert F; Lemeshow S; Sørensen HT
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1545-54. PubMed ID: 25640031
[TBL] [Abstract][Full Text] [Related]
6. Use of Antihypertensive Drugs and Risk of Malignant Melanoma: A Meta-analysis of Observational Studies.
Tang H; Fu S; Zhai S; Song Y; Han J
Drug Saf; 2018 Feb; 41(2):161-169. PubMed ID: 28905299
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review and Meta-Analyses of the Association Between Anti-Hypertensive Classes and the Risk of Falls Among Older Adults.
Ang HT; Lim KK; Kwan YH; Tan PS; Yap KZ; Banu Z; Tan CS; Fong W; Thumboo J; Ostbye T; Low LL
Drugs Aging; 2018 Jul; 35(7):625-635. PubMed ID: 29936694
[TBL] [Abstract][Full Text] [Related]
8. Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis.
Wang JL; Yin WJ; Zhou LY; Zhou G; Liu K; Hu C; Zuo XC; Wang YF
Clin Rheumatol; 2020 Mar; 39(3):769-778. PubMed ID: 31823140
[TBL] [Abstract][Full Text] [Related]
9. Atopic dermatitis, naevi count and skin cancer risk: A meta-analysis.
Gandini S; Stanganelli I; Palli D; De Giorgi V; Masala G; Caini S
J Dermatol Sci; 2016 Nov; 84(2):137-143. PubMed ID: 27461758
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-Analysis.
Mukete BN; Cassidy M; Ferdinand KC; Le Jemtel TH
Am J Cardiovasc Drugs; 2015 Aug; 15(4):243-57. PubMed ID: 26055616
[TBL] [Abstract][Full Text] [Related]
11. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies.
Tang H; Fu S; Zhai S; Song Y; Asgari MM; Han J
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):279-288. PubMed ID: 29318704
[TBL] [Abstract][Full Text] [Related]
12. Photoinduced skin reactions of cardiovascular drugs-a systematic review.
Götzinger F; Reichrath J; Millenaar D; Lauder L; Meyer MR; Böhm M; Mahfoud F
Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):420-430. PubMed ID: 35278085
[TBL] [Abstract][Full Text] [Related]
13. Melanoma and Non-Melanoma Skin Cancer Associated with Angiotensin-Converting-Enzyme Inhibitors, Angiotensin-Receptor Blockers and Thiazides: A Matched Cohort Study.
Nardone B; Majewski S; Kim AS; Kiguradze T; Martinez-Escala EM; Friedland R; Amin A; Laumann AE; Edwards BJ; Rademaker AW; Martini MC; West DP
Drug Saf; 2017 Mar; 40(3):249-255. PubMed ID: 27943160
[TBL] [Abstract][Full Text] [Related]
14. Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis.
Caini S; Cattaruzza MS; Bendinelli B; Tosti G; Masala G; Gnagnarella P; Assedi M; Stanganelli I; Palli D; Gandini S
Eur J Nutr; 2017 Feb; 56(1):1-12. PubMed ID: 27388462
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence.
Nardone B; Orrell KA; Vakharia PP; West DP
Expert Opin Drug Saf; 2018 Feb; 17(2):139-147. PubMed ID: 29103328
[TBL] [Abstract][Full Text] [Related]
16. Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC
BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547
[TBL] [Abstract][Full Text] [Related]
17. Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Koomen ER; Herings RM; Guchelaar HJ; Nijsten T
Cancer Epidemiol; 2009 Nov; 33(5):391-5. PubMed ID: 19896919
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies.
Cao L; Zhang S; Jia CM; He W; Wu LT; Li YQ; Wang W; Li Z; Ma J
BMC Urol; 2018 Mar; 18(1):17. PubMed ID: 29514670
[TBL] [Abstract][Full Text] [Related]
19. Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: a review of the literature and meta-analysis.
Caini S; Raimondi S; Johansson H; De Giorgi V; Zanna I; Palli D; Gandini S
J Dermatol Sci; 2015 Dec; 80(3):168-74. PubMed ID: 26341697
[TBL] [Abstract][Full Text] [Related]
20. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study.
Azoulay L; St-Jean A; Dahl M; Quail J; Aibibula W; Brophy JM; Chan AW; Bresee L; Carney G; Eltonsy S; Tamim H; Paterson JM; Platt RW;
J Am Acad Dermatol; 2023 Aug; 89(2):243-253. PubMed ID: 37105517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
